J.G.Chemicals Limited has informed the Exchange regarding Board meeting held on May 17, 2025.
JGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
J.G.Chemicals Limited's board, meeting on May 17, 2025, approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with an unmodified audit opinion from S. Jaykishan, Chartered Accountants. Standalone revenue from operations grew ~11% to ₹2,718.20 million (FY24: ₹2,446.49 million), while standalone PAT nearly doubled to ₹200.19 million (FY24: ₹107.87 million), with EPS rising to ₹5.11 from ₹3.36. On a consolidated basis (including subsidiary BDJ Oxides), revenue jumped ~27% to ₹8,479.44 million and PAT more than doubled to ₹667.59 million (FY24: ₹321.08 million), with EPS of ₹16.34 vs ₹9.60. The board also re-appointed M/s K. Arun & Co as Secretarial Auditor for FY 2025-26 to 2029-30.
Strong earnings beat with consolidated PAT more than doubling year-on-year, reflecting robust growth in the zinc oxide business post-IPO. However, operating cash flow turned sharply negative on both standalone (₹-134.21M vs ₹+277.39M) and consolidated (₹-111.96M vs ₹+750.64M) bases due to working capital build-up, which investors should watch. Overall positive earnings momentum with capital structure strengthening (borrowings nearly wiped out).